{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:32:20Z","timestamp":1768523540474,"version":"3.49.0"},"reference-count":152,"publisher":"Elsevier","isbn-type":[{"value":"9780443342981","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.aivir.2025.03.003","type":"book-chapter","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T01:31:58Z","timestamp":1743730318000},"page":"1-29","source":"Crossref","is-referenced-by-count":1,"title":["Molecular virulence determinants of human-pathogenic filoviruses"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.aivir.2025.03.003_bib1","doi-asserted-by":"crossref","first-page":"S957","DOI":"10.1093\/infdis\/jir326","article-title":"Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis","volume":"204","author":"Aleksandrowicz","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib2","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1128\/JVI.76.13.6841-6844.2002","article-title":"C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans","volume":"76","author":"Alvarez","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2249.2002.01800.x","article-title":"Inflammatory responses in Ebola virus-infected patients","volume":"128","author":"Baize","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002916","article-title":"Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism","volume":"8","author":"Bale","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.aivir.2025.03.003_bib5","doi-asserted-by":"crossref","first-page":"10385","DOI":"10.1128\/JVI.01452-13","article-title":"Ebolavirus VP35 coats the backbone of double-stranded RNA for interferon antagonism","volume":"87","author":"Bale","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib6","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1016\/j.jmb.2016.05.008","article-title":"Rodent-adapted filoviruses and the molecular basis of pathogenesis","volume":"428","author":"Banadyga","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib7","series-title":"Biology and Pathogenesis of Rhabdo- and Filoviruses","article-title":"Epidemiology and pathogenesis of filovirus infections","author":"Banadyga","year":"2015"},{"key":"10.1016\/bs.aivir.2025.03.003_bib8","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1038\/s41598-017-08167-8","article-title":"Ebola virus VP24 interacts with NP to facilitate nucleocapsid assembly and genome packaging","volume":"7","author":"Banadyga","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.aivir.2025.03.003_bib9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1126\/science.1172705","article-title":"Discovery of swine as a host for the Reston ebolavirus","volume":"325","author":"Barrette","year":"2009","journal-title":"Science"},{"key":"10.1016\/bs.aivir.2025.03.003_bib10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00281-017-0637-x","article-title":"Molecular pathogenesis of viral hemorrhagic fever","volume":"39","author":"Basler","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib11","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.1128\/JVI.77.14.7945-7956.2003","article-title":"The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3","volume":"77","author":"Basler","year":"2003","journal-title":"J. Virol."},{"issue":"Pt 2","key":"10.1016\/bs.aivir.2025.03.003_bib12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1099\/0022-1317-76-2-393","article-title":"The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus","volume":"76","author":"Becker","year":"1995","journal-title":"J. Gen. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib13","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001955","article-title":"ICTV virus taxonomy profile: filoviridae 2024","volume":"105","author":"Biedenkopf","year":"2024","journal-title":"J. Gen. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8081215","article-title":"Differences in viral RNA synthesis but not budding or entry contribute to the in vitro attenuation of reston virus compared to Ebola virus","volume":"8","author":"Bodmer","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/bs.aivir.2025.03.003_bib15","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1086\/379199","article-title":"Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation","volume":"188","author":"Bosio","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(77)92001-3","article-title":"Viral haemorrhagic fever in southern Sudan and northern Zaire. Preliminary studies on the aetiological agent","volume":"1","author":"Bowen","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/bs.aivir.2025.03.003_bib17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cellimm.2017.11.009","article-title":"Ebola virus secreted glycoprotein decreases the anti-viral immunity of macrophages in early inflammatory responses","volume":"324","author":"Bradley","year":"2018","journal-title":"Cell Immunol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib18","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1099\/0022-1317-82-6-1365","article-title":"The role of the Type I interferon response in the resistance of mice to filovirus infection","volume":"82","author":"Bray","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib19","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.biocel.2005.02.018","article-title":"Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever","volume":"37","author":"Bray","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib20","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1128\/JVI.02199-05","article-title":"Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha\/beta interferon production induced by RIG-I signaling","volume":"80","author":"Cardenas","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib21","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.5666.2","article-title":"Correlating the ability of VP24 protein from Ebola and Marburg viruses to bind human karyopherin to their immune suppression mechanism and pathogenicity using computational methods","volume":"3","author":"Chakraborty","year":"2014","journal-title":"F1000Research"},{"key":"10.1016\/bs.aivir.2025.03.003_bib22","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1110656","article-title":"Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection","volume":"308","author":"Chandran","year":"2005","journal-title":"Science"},{"key":"10.1016\/bs.aivir.2025.03.003_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000493","article-title":"Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery","volume":"5","author":"Chang","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.aivir.2025.03.003_bib24","first-page":"S448","article-title":"Marburg and Ravn viruses fail to cause disease in the domestic ferret (Mustela putorius furo)","volume":"218","author":"Cross","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/infdis\/jiw209","article-title":"The domestic ferret (Mustela putorius furo) as a lethal infection model for 3 species of Ebolavirus","volume":"214","author":"Cross","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib26","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/cid\/ciw601","article-title":"Resurgence of Ebola virus disease in guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days","volume":"63","author":"Diallo","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/bs.aivir.2025.03.003_bib27","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1086\/514284","article-title":"Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit","volume":"179","author":"Dowell","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012065","article-title":"Ebola virus disease sequelae and viral persistence in animal models: Implications for the future","volume":"20","author":"Durant","year":"2024","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/bs.aivir.2025.03.003_bib29","doi-asserted-by":"crossref","first-page":"S991","DOI":"10.1093\/infdis\/jir336","article-title":"Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus","volume":"204","author":"Ebihara","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0020073","article-title":"Molecular determinants of Ebola virus virulence in mice","volume":"2","author":"Ebihara","year":"2006","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.aivir.2025.03.003_bib31","unstructured":"EMA, E.M.A., 2024. Supporting the development of Ebola medicines [Online]. Available: https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/public-health-threats\/ebola (accessed 12 December 2024)."},{"key":"10.1016\/bs.aivir.2025.03.003_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004509","article-title":"Shed GP of Ebola virus triggers immune activation and increased vascular permeability","volume":"10","author":"Escudero-Perez","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.aivir.2025.03.003_bib33","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/cdd.2015.67","article-title":"Molecular mechanisms of Ebola virus pathogenesis: focus on cell death","volume":"22","author":"Falasca","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/bs.aivir.2025.03.003_bib34","unstructured":"FDA, F.A.D.A., 2023. Ebola Preparedness and Response Updates from FDA [Online]. Available: https:\/\/www.fda.gov\/emergency-preparedness-and-response\/mcm-issues\/ebola-preparedness-and-response-updates-fda (accessed 10 September 2024)."},{"key":"10.1016\/bs.aivir.2025.03.003_bib35","doi-asserted-by":"crossref","first-page":"14440","DOI":"10.1128\/JVI.02069-14","article-title":"The VP40 protein of Marburg virus exhibits impaired budding and increased sensitivity to human tetherin following mouse adaptation","volume":"88","author":"Feagins","year":"2014","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/bs.aivir.2025.03.003_bib36","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1093\/infdis\/jiv010","article-title":"Amino acid residue at position 79 of Marburg virus VP40 confers interferon antagonism in mouse cells","volume":"212","author":"Feagins","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib37","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1128\/jvi.70.4.2208-2214.1996","article-title":"Filovirus-induced endothelial leakage triggered by infected monocytes\/macrophages","volume":"70","author":"Feldmann","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-1702(92)90027-7","article-title":"Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle","volume":"24","author":"Feldmann","year":"1992","journal-title":"Virus Res."},{"key":"10.1016\/bs.aivir.2025.03.003_bib39","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3201\/eid2107.150253","article-title":"Ebola virus stability on surfaces and in fluids in simulated outbreak environments","volume":"21","author":"Fischer","year":"2015","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/bs.aivir.2025.03.003_bib40","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1086\/514285","article-title":"Human infection due to Ebola virus, subtype Cote d\u2019Ivoire: clinical and biologic presentation","volume":"179","author":"Formenty","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001098","article-title":"Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein","volume":"6","author":"Francica","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.aivir.2025.03.003_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009937","article-title":"The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway","volume":"17","author":"Furuyama","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.aivir.2025.03.003_bib43","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","article-title":"Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection","volume":"163","author":"Geisbert","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib44","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/S0002-9440(10)63592-4","article-title":"Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells","volume":"163","author":"Geisbert","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0168-1702(95)00080-1","article-title":"Differentiation of filoviruses by electron microscopy","volume":"39","author":"Geisbert","year":"1995","journal-title":"Virus Res."},{"key":"10.1016\/bs.aivir.2025.03.003_bib46","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41564-018-0227-2","article-title":"The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses","volume":"3","author":"Goldstein","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib47","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.virol.2005.06.026","article-title":"LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus","volume":"340","author":"Gramberg","year":"2005","journal-title":"Virology"},{"key":"10.1016\/bs.aivir.2025.03.003_bib48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virusres.2008.10.017","article-title":"The Ebola virus ribonucleoprotein complex: a novel VP30\u2013L interaction identified","volume":"140","author":"Groseth","year":"2009","journal-title":"Virus Res."},{"key":"10.1016\/bs.aivir.2025.03.003_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002847","article-title":"The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo","volume":"8","author":"Groseth","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.aivir.2025.03.003_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpj.2017.11.1535","article-title":"Ebola virus delta-peptide acts as an enterotoxic viroporin in vivo","volume":"114","author":"Guha","year":"2018","journal-title":"Biophysical J."},{"key":"10.1016\/bs.aivir.2025.03.003_bib51","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.virol.2010.03.024","article-title":"Reduced virus replication, proinflammatory cytokine production, and delayed macrophage cell death in human PBMCs infected with the newly discovered Bundibugyo ebolavirus relative to Zaire ebolavirus","volume":"402","author":"Gupta","year":"2010","journal-title":"Virology"},{"key":"10.1016\/bs.aivir.2025.03.003_bib52","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3201\/eid1807.111654","article-title":"Ebola virus antibodies in fruit bats, Ghana, West Africa","volume":"18","author":"Hayman","year":"2012","journal-title":"Emerg. Infect. Dis."},{"issue":"2","key":"10.1016\/bs.aivir.2025.03.003_bib53","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1093\/infdis\/jiv111","article-title":"Soluble glycoprotein is not required for Ebola virus virulence in guinea pigs","volume":"212","author":"Hoenen","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib54","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1097-2765(02)00588-9","article-title":"The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein","volume":"10","author":"Huang","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/bs.aivir.2025.03.003_bib55","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S1473-3099(15)00144-9","article-title":"Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study","volume":"15","author":"Hunt","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib56","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0140-6736(90)90737-P","article-title":"Preliminary report: isolation of Ebola virus from monkeys imported to USA","volume":"335","author":"Jahrling","year":"1990","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/bs.aivir.2025.03.003_bib57","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1086\/514310","article-title":"Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections","volume":"179","author":"Jahrling","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib58","first-page":"115","article-title":"Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989-1990 U.S. epizootic","volume":"11","author":"Jahrling","year":"1996","journal-title":"Arch. Virol. Suppl."},{"key":"10.1016\/bs.aivir.2025.03.003_bib59","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12985-015-0331-3","article-title":"Molecular evidence of Ebola Reston virus infection in Philippine bats","volume":"12","author":"Jayme","year":"2015","journal-title":"Virol. J."},{"key":"10.1016\/bs.aivir.2025.03.003_bib60","doi-asserted-by":"crossref","first-page":"8967","DOI":"10.1128\/JVI.02523-06","article-title":"Ebola virus VP30 is an RNA binding protein","volume":"81","author":"John","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib61","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(77)92000-1","article-title":"Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire","volume":"1","author":"Johnson","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/bs.aivir.2025.03.003_bib62","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1128\/JVI.80.6.3009-3020.2006","article-title":"Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence","volume":"80","author":"Kash","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib63","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41586-021-03901-9","article-title":"Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks","volume":"597","author":"Keita","year":"2021","journal-title":"Nature"},{"key":"10.1016\/bs.aivir.2025.03.003_bib64","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41426-018-0067-4","article-title":"Re-emergence of Lloviu virus in Miniopterus schreibersii bats, Hungary, 2016","volume":"7","author":"Kemenesi","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/bs.aivir.2025.03.003_bib65","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41467-022-29298-1","article-title":"Isolation of infectious Lloviu virus from Schreiber\u2019s bats in Hungary","volume":"13","author":"Kemenesi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/bs.aivir.2025.03.003_bib66","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1073\/pnas.0910547107","article-title":"Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression","volume":"107","author":"Kimberlin","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.aivir.2025.03.003_bib67","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1128\/JVI.02670-15","article-title":"A single amino acid change in the marburg virus matrix protein VP40 provides a replicative advantage in a species-specific manner","volume":"90","author":"Koehler","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib68","doi-asserted-by":"crossref","first-page":"8426","DOI":"10.1073\/pnas.1019030108","article-title":"T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus","volume":"108","author":"Kondratowicz","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.aivir.2025.03.003_bib69","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3389\/fmicb.2017.01571","article-title":"Ebola virus glycoprotein induces an innate immune response in vivo via TLR4","volume":"8","author":"Lai","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.coviro.2016.11.013","article-title":"Human transmission of Ebola virus","volume":"22","author":"Lawrence","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib71","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/438575a","article-title":"Fruit bats as reservoirs of Ebola virus","volume":"438","author":"Leroy","year":"2005","journal-title":"Nature"},{"key":"10.1016\/bs.aivir.2025.03.003_bib72","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nsmb.1765","article-title":"Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35","volume":"17","author":"Leung","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib73","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.chom.2013.06.010","article-title":"Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome","volume":"14","author":"Luthra","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/bs.aivir.2025.03.003_bib74","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.4049\/jimmunol.170.6.2797","article-title":"Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses","volume":"170","author":"Mahanty","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib75","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1128\/JVI.02545-05","article-title":"The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR","volume":"80","author":"Marzi","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib76","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.virol.2006.04.038","article-title":"Modulation of virion incorporation of Ebolavirus glycoprotein: effects on attachment, cellular entry and neutralization","volume":"352","author":"Marzi","year":"2006","journal-title":"Virology"},{"key":"10.1016\/bs.aivir.2025.03.003_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001923","article-title":"Cathepsin B & L are not required for ebola virus replication","volume":"6","author":"Marzi","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib78","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMoa1509773","article-title":"Molecular evidence of sexual transmission of Ebola virus","volume":"373","author":"Mate","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/bs.aivir.2025.03.003_bib79","doi-asserted-by":"crossref","first-page":"S1011","DOI":"10.1093\/infdis\/jir338","article-title":"VP24 is a molecular determinant of Ebola virus virulence in guinea pigs","volume":"204","author":"Mateo","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.606456","article-title":"Type I interferon (IFN)-regulated activation of canonical and non-canonical signaling pathways","volume":"11","author":"Mazewski","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib81","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","article-title":"The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts","volume":"159","author":"Mehand","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/bs.aivir.2025.03.003_bib82","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1128\/JVI.02190-10","article-title":"A new Ebola virus nonstructural glycoprotein expressed through RNA editing","volume":"85","author":"Mehedi","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib83","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1089\/vim.2014.0091","article-title":"Ebola virus infection induces irregular dendritic cell gene expression","volume":"28","author":"Melanson","year":"2015","journal-title":"Viral Immunol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110172","article-title":"Ebola virus delta peptide is an enterotoxin","volume":"38","author":"Melnik","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/bs.aivir.2025.03.003_bib85","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrmicro3524","article-title":"Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus","volume":"13","author":"Messaoudi","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib86","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0140-6736(91)91199-5","article-title":"Seroepidemiological study of filovirus related to Ebola in the Philippines","volume":"337","author":"Miranda","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/bs.aivir.2025.03.003_bib87","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/JVI.06346-11","article-title":"Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences","volume":"86","author":"Misasi","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003065","article-title":"Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus","volume":"8","author":"Mohan","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.aivir.2025.03.003_bib89","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/JVI.73.3.2333-2342.1999","article-title":"Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems","volume":"73","author":"Muhlberger","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001121","article-title":"Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner","volume":"6","author":"Nanbo","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.aivir.2025.03.003_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002304","article-title":"Discovery of an ebolavirus-like filovirus in europe","volume":"7","author":"Negredo","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.aivir.2025.03.003_bib92","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1099\/vir.0.019794-0","article-title":"Characterization of the Ebola virus nucleoprotein-RNA complex","volume":"91","author":"Noda","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib93","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00179-17","article-title":"Ebolaviruses associated with differential pathogenicity induce distinct host responses in human macrophages","volume":"91","author":"Olejnik","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib94","article-title":"Transmission of Ebola viruses: what we know and what we do not know","volume":"6","author":"Osterholm","year":"2015","journal-title":"mBio"},{"key":"10.1016\/bs.aivir.2025.03.003_bib95","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00705-012-1477-6","article-title":"Reston virus in domestic pigs in China","volume":"159","author":"Pan","year":"2014","journal-title":"Arch. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib96","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(77)92002-5","article-title":"Isolation of Marburg-like virus from a case of haemorrhagic fever in Zaire","volume":"1","author":"Pattyn","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/bs.aivir.2025.03.003_bib97","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1471-2334-9-159","article-title":"Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus","volume":"9","author":"Pourrut","year":"2009","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib98","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3201\/eid2105.150041","article-title":"Postmortem stability of Ebola virus","volume":"21","author":"Prescott","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib99","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1128\/JVI.01875-08","article-title":"Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1","volume":"83","author":"Prins","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib100","doi-asserted-by":"crossref","first-page":"20661","DOI":"10.1073\/pnas.1213559109","article-title":"Structural basis for Marburg virus VP35-mediated immune evasion mechanisms","volume":"109","author":"Ramanan","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.aivir.2025.03.003_bib101","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1128\/JVI.02349-05","article-title":"Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation","volume":"80","author":"Reid","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib102","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/rcm.4410","article-title":"Identification of N-glycans from Ebola virus glycoproteins by matrix-assisted laser desorption\/ionisation time-of-flight and negative ion electrospray tandem mass spectrometry","volume":"24","author":"Ritchie","year":"2010","journal-title":"Rapid Commun. Mass. Spectrom."},{"key":"10.1016\/bs.aivir.2025.03.003_bib103","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1016\/S1473-3099(17)30234-7","article-title":"Insights from clinical research completed during the west Africa Ebola virus disease epidemic","volume":"17","author":"Rojek","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001110","article-title":"Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes","volume":"6","author":"Saeed","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.aivir.2025.03.003_bib105","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0168-1702(93)90063-S","article-title":"Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus","volume":"29","author":"Sanchez","year":"1993","journal-title":"Virus Res."},{"key":"10.1016\/bs.aivir.2025.03.003_bib106","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.1128\/JVI.78.19.10370-10377.2004","article-title":"Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels","volume":"78","author":"Sanchez","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib107","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1128\/JVI.72.8.6442-6447.1998","article-title":"Biochemical analysis of the secreted and virion glycoproteins of Ebola virus","volume":"72","author":"Sanchez","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111562","article-title":"Activation of Toll-like receptor 4 by Ebola virus-shed glycoprotein is direct and requires the internal fusion loop but not glycosylation","volume":"41","author":"Scherm","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/bs.aivir.2025.03.003_bib109","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1086\/517704","article-title":"Marburg and Ebola hemorrhagic fevers: does the primary course of infection depend on the accessibility of organ-specific macrophages?","volume":"27","author":"Schnittler","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib110","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01715-16","article-title":"VP24-Karyopherin alpha binding affinities differ between ebolavirus species, influencing interferon inhibition and VP24 stability","volume":"91","author":"Schwarz","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib111","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbalip.2004.08.006","article-title":"The NPC1 protein: structure implies function","volume":"1685","author":"Scott","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/bs.aivir.2025.03.003_bib112","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12985-019-1272-z","article-title":"Marburg virus pathogenesis \u2013 differences and similarities in humans and animal models","volume":"16","author":"Shifflett","year":"2019","journal-title":"Virol. J."},{"key":"10.1016\/bs.aivir.2025.03.003_bib113","doi-asserted-by":"crossref","first-page":"10109","DOI":"10.1128\/JVI.01157-06","article-title":"Tyro3 family-mediated cell entry of Ebola and Marburg viruses","volume":"80","author":"Shimojima","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib114","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.1093\/nar\/gkz340","article-title":"Ebola virus VP35 has novel NTPase and helicase-like activities","volume":"47","author":"Shu","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/bs.aivir.2025.03.003_bib115","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1055\/s-0028-1106144","article-title":"On the etiology of an unknown human infection originating from monkeys","volume":"92","author":"Siegert","year":"1967","journal-title":"Dtsch. Med. Wochenschr."},{"key":"10.1016\/bs.aivir.2025.03.003_bib116","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/viro.2002.1730","article-title":"DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells","volume":"305","author":"Simmons","year":"2003","journal-title":"Virology"},{"key":"10.1016\/bs.aivir.2025.03.003_bib117","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/jvi.76.5.2518-2528.2002","article-title":"Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence","volume":"76","author":"Simmons","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib118","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3201\/eid2206.160021","article-title":"Perspectives on West Africa Ebola virus disease outbreak, 2013\u20132016","volume":"22","author":"Spengler","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib119","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/infdis\/jix562","article-title":"Severity of disease in humanized mice infected with ebola virus or reston virus is associated with magnitude of early viral replication in liver","volume":"217","author":"Spengler","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.virusres.2010.07.015","article-title":"Genetic factors of Ebola virus virulence in guinea pigs","volume":"153","author":"Subbotina","year":"2010","journal-title":"Virus Res."},{"key":"10.1016\/bs.aivir.2025.03.003_bib121","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.3201\/eid1312.071115","article-title":"Studies of reservoir hosts for Marburg virus","volume":"13","author":"Swanepoel","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib122","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1128\/JVI.78.6.2943-2947.2004","article-title":"Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry","volume":"78","author":"Takada","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib123","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/viro.2000.0601","article-title":"Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry","volume":"278","author":"Takada","year":"2000","journal-title":"Virology"},{"key":"10.1016\/bs.aivir.2025.03.003_bib124","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0042-6822(03)00260-5","article-title":"Oligomerization and polymerization of the filovirus matrix protein VP40","volume":"312","author":"Timmins","year":"2003","journal-title":"Virology"},{"key":"10.1016\/bs.aivir.2025.03.003_bib125","doi-asserted-by":"crossref","first-page":"11310","DOI":"10.1038\/s41598-023-38364-7","article-title":"Isolation and genome characterization of Lloviu virus from Italian Schreibers\u2019s bats","volume":"13","author":"Toth","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.aivir.2025.03.003_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000536","article-title":"Isolation of genetically diverse Marburg viruses from Egyptian fruit bats","volume":"5","author":"Towner","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.aivir.2025.03.003_bib127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000764","article-title":"Marburg virus infection detected in a common African bat","volume":"2","author":"Towner","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/bs.aivir.2025.03.003_bib128","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1128\/JVI.02575-10","article-title":"Marburg virus VP40 antagonizes interferon signaling in a species-specific manner","volume":"85","author":"Valmas","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000721","article-title":"Marburg virus evades interferon responses by a mechanism distinct from ebola virus","volume":"6","author":"Valmas","year":"2010","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/bs.aivir.2025.03.003_bib130","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.1086\/514283","article-title":"Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection","volume":"179","author":"Villinger","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib131","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/viro.2000.0572","article-title":"Molecular characterization of guinea pig-adapted variants of Ebola virus","volume":"277","author":"Volchkov","year":"2000","journal-title":"Virology"},{"key":"10.1016\/bs.aivir.2025.03.003_bib132","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1073\/pnas.95.10.5762","article-title":"Processing of the Ebola virus glycoprotein by the proprotein convertase furin","volume":"95","author":"Volchkov","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/bs.aivir.2025.03.003_bib133","doi-asserted-by":"crossref","first-page":"S941","DOI":"10.1093\/infdis\/jir321","article-title":"Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs","volume":"204","author":"Volchkova","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/bs.aivir.2025.03.003_bib134","doi-asserted-by":"crossref","first-page":"S226","DOI":"10.1093\/infdis\/jiv309","article-title":"RNA editing of the GP gene of Ebola virus is an important pathogenicity factor","volume":"212","author":"Volchkova","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib135","doi-asserted-by":"crossref","first-page":"10442","DOI":"10.1128\/JVI.79.16.10442-10450.2005","article-title":"Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function","volume":"79","author":"Wahl-Jensen","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib136","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature24490","article-title":"Structure and assembly of the Ebola virus nucleocapsid","volume":"551","author":"Wan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/bs.aivir.2025.03.003_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.08.044","article-title":"Intracellular Ebola virus nucleocapsid assembly revealed by in situ cryo-electron tomography","author":"Watanabe","year":"2024","journal-title":"Cell"},{"key":"10.1016\/bs.aivir.2025.03.003_bib138","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1128\/JVI.80.8.3743-3751.2006","article-title":"Functional mapping of the nucleoprotein of Ebola virus","volume":"80","author":"Watanabe","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000837","article-title":"Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis","volume":"4","author":"Wauquier","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib140","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1093\/infdis\/jiw167","article-title":"Ebola virus stability under hospital and environmental conditions","volume":"214","author":"Westhoff Smith","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/bs.aivir.2025.03.003_bib141","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.celrep.2018.01.008","article-title":"Active Ebola virus replication and heterogeneous evolutionary rates in EVD survivors","volume":"22","author":"Whitmer","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/bs.aivir.2025.03.003_bib142","unstructured":"WHO, W.H.O., 2023. Marburg virus disease \u2013 Equatorial Guinea and the United Republic of Tanzania \u2013 Disease Outbreak News [Online]. Available: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2023-DON467 (accessed 12 September 2024)."},{"key":"10.1016\/bs.aivir.2025.03.003_bib143","unstructured":"WHO, W.H.O., 2024a. Ebola Disease Outbreaks Since 1976 [Online]. Available: https:\/\/www.cdc.gov\/ebola\/outbreaks\/index.html (accessed 12 September 2024)."},{"key":"10.1016\/bs.aivir.2025.03.003_bib144","unstructured":"WHO, W.H.O., 2024b. History of Marburg Disease Outbreaks [Online]. Available: https:\/\/www.cdc.gov\/marburg\/outbreaks\/index.html (accessed)."},{"key":"10.1016\/bs.aivir.2025.03.003_bib145","unstructured":"WHO, W.H.O., 2024c. Marburg virus disease \u2013 Rwanda [Online]. Available: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2024-DON537 (accessed 16 October 2024)."},{"key":"10.1016\/bs.aivir.2025.03.003_bib146","unstructured":"WHO, W.H.O., 2025a. Outbreak of suspected Marburg Virus Disease \u2013 United Republic of Tanzania - Disease Outbreak News [Online]. Available: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2025-DON552 (accessed)."},{"key":"10.1016\/bs.aivir.2025.03.003_bib147","unstructured":"WHO, W.H.O., 2025b. Sudan virus disease \u2013 Uganda \u2013 Disease Outbreak News [Online]. Available: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2025-DON555 (accessed)."},{"key":"10.1016\/bs.aivir.2025.03.003_bib148","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/JVI.01832-09","article-title":"A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry","volume":"84","author":"Wong","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2025.03.003_bib149","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/21505594.2021.1898169","article-title":"Pathogenicity and virulence of Ebolaviruses with species- and variant-specificity","volume":"12","author":"Yamaoka","year":"2021","journal-title":"Virulence"},{"key":"10.1016\/bs.aivir.2025.03.003_bib150","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/78654","article-title":"Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury","volume":"6","author":"Yang","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/bs.aivir.2025.03.003_bib151","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41586-022-05271-2","article-title":"Structure of the Ebola virus polymerase complex","volume":"610","author":"Yuan","year":"2022","journal-title":"Nature"},{"key":"10.1016\/bs.aivir.2025.03.003_bib152","doi-asserted-by":"crossref","DOI":"10.3390\/v11110999","article-title":"The roles of ebola virus soluble glycoprotein in replication, pathogenesis, and countermeasure development","volume":"11","author":"Zhu","year":"2019","journal-title":"Viruses"}],"container-title":["Advances in Virus Research","Biosafety Level 4 (BSL4) \u2013 Virus Research at the Highest Level of Biosafety and Biosecurity Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S006535272500003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S006535272500003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T04:18:48Z","timestamp":1762229928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S006535272500003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443342981"],"references-count":152,"URL":"https:\/\/doi.org\/10.1016\/bs.aivir.2025.03.003","relation":{},"ISSN":["0065-3527"],"issn-type":[{"value":"0065-3527","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}